Institutional Review Board

by ;
Format: Hardcover
Pub. Date: 2001-11-01
Publisher(s): Jones & Bartlett Learning
  • Free Shipping Icon

    This Item Qualifies for Free Shipping!*

    *Excludes marketplace orders.

List Price: $203.65

Rent Textbook

Select for Price
There was a problem. Please try again later.

New Textbook

We're Sorry
Sold Out

Used Textbook

We're Sorry
Sold Out

eTextbook

We're Sorry
Not Available

How Marketplace Works:

  • This item is offered by an independent seller and not shipped from our warehouse
  • Item details like edition and cover design may differ from our description; see seller's comments before ordering.
  • Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
  • Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
  • Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.

Summary

Univ. of Florida Health Science Center. Provides a step-by-step approach to practical details of the Institutional Review Board (IRB) administration. Includes case studies, sample forms, and sample policy documents. Uses a topic- specific approach to address the issues by review boards and provides algorithms and lists of approval criteria for their resolution.

Table of Contents

Acknowledgments xiii
Foreword: Jesse's Intent xv
Paul Gelsinger
Preface xxv
Robert J. Amdur
Elizabeth A. Bankert
Contributing Authors xxvii
PART 1 Background and Overview Topics 2(31)
An Ethics Primer for IRBs
3(6)
Harold Y. Vanderpool
Reflections from the Office of the Inspector General
9(4)
Mark R. Yessian
A Unified Human-Research Protection Program
13(4)
Sanford Chodosh
A Shared Responsibility for Protecting Human Subjects
17(5)
Steven Peckman
The Tension Between Science and Ethics
22(2)
Marian G. Secundy
A Brief History of PRIM&R and IRB Education
24(3)
Joan Rachlin
The IRB: Definition and Federal Oversight
27(3)
Robert J. Amdur
The Limits of IRB Authority
30(3)
Robert J. Amdur
PART 2 Organizing the Office 33(44)
Administrative Reporting Structure for the IRB
35(2)
Ernest D. Prentice
Sally L. Mann
Bruce G. Gordon
Documenting Compliance with Federal Regulations
37(6)
Deborah L. Barnard
IRB Policies and Procedures
43(7)
Celia S. Walker
Tracking Systems
50(8)
Patricia M. Scannell
Support Staff
58(8)
Helen McGough
Audit Systems
66(9)
Ernest D. Prentice
Ada Sue Selwitz
Gwenn S. F. Oki
Charging for IRB Review
75(2)
Ernest D. Prentice
Sally L. Mann
Bruce G. Gordon
PART 3 Organizing the IRB Committee 77(32)
Reflections on Chairing an IRB
79(3)
Robert J. Levine
The IRB Chair
82(4)
Robert J. Amdur
Robert M. Nelson
The IRB Administrative Director
86(5)
Elizabeth A. Bankert
Robert J. Amdur
The Role of an Attorney
91(5)
Susan Nicholson
Committee Size, Alternates, and Consultants
96(3)
Robert J. Amdur
Elizabeth A. Bankert
Length, Frequency, and Time of IRB Meetings
99(2)
Robert J. Amdur
Elizabeth A. Bankert
IRB Subcommittees
101(4)
Robert J. Amdur
Elizabeth A. Bankert
Social Science Versus Biomedical IRBs
105(4)
Robert J. Amdur
Elizabeth A. Bankert
PART 4 Review Categories Other Than Full Board Review 109(32)
Exempt from IRB Review
111(3)
Ernest D. Prentice
Gwen S. F. Oki
Expedited IRB Review
114(4)
Gwen S. F. Oki
John Zaia
Identifying Research Intent
118(7)
Robert J. Amdur
Marjorie A. Speers
IRB Triage of Projects That Involve Medical Record Review
125(4)
Robert J. Amdur
Marjorie A. Speers
Elizabeth A. Bankert
``Compassionate Use'' and Emergency Exemption from IRB Approval
129(3)
Elizabeth A. Bankert
Robert J. Amdur
Waiver of Consent in Emergency Medicine Research
132(9)
Helen McGough
PART 5 Initial Protocol Review and the Full-Committee Meeting 141(90)
Overview of Initial Protocol Review
143(9)
Susan Z. Kornetsky
Evaluating Study Design and Quality
152(3)
Robert J. Amdur
The Study Population: Women, Minorities, and Children
155(5)
Amy L. Davis
Community Consultation to Evaluate Group Risk
160(5)
William L. Freeman
Francine C. Romero
Requiring Birth Control to Participate in Research
165(4)
Bruce G. Gordon
Ernest D. Prentice
Privacy and Confidentiality
169(7)
David G. Forster
Recruitment of Research Subjects
176(4)
Felix A. Khin-Maung-Gyi
Matthew D. Whalen
Advertisements for Research
180(5)
Rachel Homer
Rachel Krebs
Linda Medwar
Paying Research Subjects
185(6)
Bruce G. Gordon
Joseph Brown
Christopher Kratochvil
Ernest D. Prentice
Provisions for Data Monitoring
191(6)
Robert J. Amdur
Conflict of Interest: Researchers
197(7)
Daniel K. Nelson
Conflict of Interest: Recruitment Incentives
204(4)
Daniel K. Nelson
Conflict of Interest: IRBs
208(6)
Daniel K. Nelson
Administrative Tasks Before the Meeting
214(5)
Rebecca Carson Rogers
Elizabeth A. Bankert
Guidelines for Review, Discussion, and Voting
219(7)
Robert J. Amdur
Elizabeth A. Bankert
Administrative Tasks After Each IRB Meeting
226(5)
Jan Trott
Elizabeth A. Bankert
PART 6 Informed Consent 231(56)
The IRB's Role in Editing the Consent Document
233(3)
Robin L. Penslar
The Consent Document
236(3)
Angela J. Bowen
Exculpatory Language in Informed Consent Documents
239(3)
Michele Russell-Einhorn
Thomas Puglisi
Requiring a Witness Signature on the Consent Form
242(2)
Michele Russell-Einhorn
Thomas Puglisi
Deception of Research Subjects
244(6)
Laurie Slone
Jay Hull
Research Without Consent or Documentation Thereof
250(6)
Marianne M. Elliott
Active Versus Passive Consent
256(2)
Linda J. Kobokovich
Robert J. Amdur
Elizabeth A. Bankert
Selecting a Surrogate to Consent to Medical Research
258(7)
Robert J. Amdur
Natalie Bachir
Elizabeth Stanton
Research-Related Injuries
265(3)
Daniel R. Vasgird
Informing Subjects About Research Results
268(4)
Thomas G. Keens
Explaining the Cost of Research Participation
272(5)
Kevin M. Hunt
Improving Informed Consent
277(5)
Jeffrey A. Cooper
Pamela Turner
Informed Consent Evaluation Feedback Tool
282(5)
Elizabeth A. Bankert
Robert J. Amdur
PART 7 Continuing Review 287(24)
Revisions of an Approved Protocol
289(4)
Sherry Bye
Protocol Renewal
293(4)
Karen M. Hansen
IRB Review of Adverse Events
297(6)
Ernest D. Prentice
Kevin J. Epperson
Christopher J. Kratochvil
Bruce G. Gordon
Data and Safety Monitoring
303(3)
J. Allen McCutchan
Noncompliance/Complaint Procedure
306(5)
Lucille Pearson
PART 8 Administrative and Regulatory Issues 311(60)
OHRP Federal-Wide Assurance
313(3)
Jeffrey M. Cohen
International Conference on Harmonisation
316(5)
David G. Forster
Gary L. Chadwick
Gene Therapy Oversight
321(2)
Bambi Grilley
Understanding the FDA's IND Process
323(6)
Dale E. Hammerschmidt
Differences Between DHHS and FDA Regulations
329(2)
Robert J. Amdur
Veterans Administration Research Guidelines
331(8)
Peter Marshall
State Law
339(3)
Sandra P. Kaltman
John M. Isidor
IRB Member Liability
342(3)
Sandra P. Kaltman
John M. Isidor
Certificates of Confidentiality
345(2)
Sandra P. Kaltman
John M. Isidor
Educating IRB Members
347(2)
Jeffrey A. Cooper
Pamela Turner
Investigator Training
349(4)
Jeffrey A. Cooper
Pamela Turner
Accreditation of an IRB
353(3)
Susan S. Fish
Certification of IRB Professionals
356(3)
Susan J. Delano
Sallyann Henry
Gary L. Chadwick
Preparing for an FDA Audit
359(6)
Gary L. Chadwick
Preparing for an OHRP Site Visit
365(6)
Thomas Puglisi
Michele Russell-Einhorn
PART 9 Issues Based on Study Population 371(30)
Research Involving Fetuses and In Vitro Fertilization
373(7)
Ronald M. Green
Research Involving Pregnant Women
380(3)
Angela J. Bowen
Research Involving Children
383(6)
Robert M. Nelson
Research Involving Adults with Decisional Impairment
389(5)
Susan J. Delano
Research Involving Prisoners
394(5)
Ernest D. Prentice
Bruce G. Gordon
Christopher J. Kratochvil
Gail D. Kotu
Research Involving College Students
399(2)
Jennifer J. Tickle
Todd F. Heatherton
PART 10 IRB Issues Based On Study Design or Category 401(86)
Qualitative Social Science Research
403(4)
Dean R. Gallant
Ethnographic Research
407(8)
Elisabeth Smith Parrott
Oral History Research
415(4)
Alan Bliss
Health Services Research
419(5)
Ann Barry Flood
Epidemiology/Public Health Research
424(4)
Marjorie A. Speers
Survey Research
428(6)
J. Michael Oakes
Research Involving a Medical Device
434(7)
Erica J. Heath
Humanitarian Use Devices
441(2)
Robert J. Amdur
Banking of Biological Materials for Research
443(7)
Karen M. Hansen
Robert J. Amdur
Elizabeth A. Bankert
The Placebo-Controlled Clinical Trial
450(8)
Robert J. Amdur
C. J. Biddle
Research Involving Sham Surgery
458(3)
Robert M. Zwolak
Treatment-Withholding Studies in Psychiatry
461(4)
Richard B. Ferrell
Phase I Oncology Trials
465(11)
Matthew Miller
Research Involving Genetic Testing
476(5)
Eric C. Larsen
International Research
481(2)
David A. Borasky
Alternative Medicine Research
483(4)
Timothy Callahan
PART 11 Reference Material and Contact Information 487(84)
Elizabeth A. Bankert
Ethical Codes
489(12)
The Nuremberg Code
490(2)
The Belmont Report
492(7)
World Medical Association Declaration of Helsinki
499(2)
Selected U.S. Government Regulations
501(33)
Code of Federal Regulations: Title 45, Part 46
502(15)
Code of Federal Regulations: Title 21, Part 50
517(6)
Code of Federal Regulations: Title 21, Part 56
523(9)
Expedited IRB Review Criteria
532(2)
U.S. Government Guidance and Resources
534(1)
International Guidelines
535(1)
Selected Books
536(1)
Periodicals and IRB Forum
537(1)
Video Recordings
538(1)
Selected Organizations
539(1)
Standardized IRB Forms
540(31)
Elizabeth A. Bankert
Index 571

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.